Association of Plasma Leucine-Rich Alpha-2 Glycoprotein 1 (LRG1) with All-Cause and Cause-Specific Mortality in Individuals with Type 2 Diabetes.
Jian-Jun LiuSharon L T PekSylvia LiuJiexun WangJanus LeeKeven AngYi Ming ShaoResham L GurungSubramaniam TavintharanWern Ee TangChee Fang SumJian-Jun LiuPublished in: Clinical chemistry (2022)
Plasma LRG1 predicts risk for all-cause mortality and mortality attributable to cardiovascular disease, infection, and renal disease independent of known cardio-renal risk factors. It may be a potential novel biomarker to improve risk stratification in individuals with type 2 diabetes.